[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-362183-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-362183-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","impact-of-covid-19-restrictions-on-thyroid-cancer-diagnoses-in-a-comprehensive-cancer-center-2017-2023-research-report","Impact of COVID-19 restrictions on thyroid cancer diagnoses in a comprehensive cancer center (2017-2023) - Research Report","","The Coronavirus 2019 (COVID-19) pandemic disrupted U.S. healthcare delivery, causing a sharp decline in outpatient visits. Because thyroid nodule evaluation and diagnosis typically occur in outpatient settings, the study assessed whether these disruptions reduced thyroid cancer incidence. Adults with pathologically confirmed thyroid cancer diagnoses from 2017–2023 were analyzed across pre-pandemic, pandemic, and COVID-years periods at a comprehensive cancer center. Results showed a steady decline in incidence through 2022 and stable tumor size, treatment, and 1-year mortality.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/impact-of-covid-19-restrictions-on-thyroid-cancer-diagnoses-in-a-comprehensive-cancer-center-2017-2023-research-report/362183/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/impact-of-covid-19-restrictions-on-thyroid-cancer-diagnoses-in-a-comprehensive-cancer-center-2017-2023-research-report/362183.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",17,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What time periods were compared for thyroid cancer diagnoses?","Question",{"text":63,"@type":64},"The analysis compared pre-pandemic (Jan 2017–Mar 2020), pandemic (Apr 2020–Mar 2021), and COVID-years (Apr 2021–Dec 2023).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did thyroid cancer incidence change from 2017 to 2022?",{"text":68,"@type":64},"Age- and sex-adjusted incidence declined from 34 to 15.6 per 100,000 persons between 2017 and 2022, with an average APC of −14.4%.",{"name":70,"@type":61,"acceptedAnswer":71},"Were tumor size and 1-year mortality different across the timeframes?",{"text":72,"@type":64},"No significant differences were observed in tumor size, surgical treatment, gender ratio, or 1-year all-cause mortality across the evaluated timeframes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},362183,1790212004,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":124,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","OPEN ACCESS  \nCitation: Mann H, Dimon E, Zhang Y, Arroyo N, Adil A, Zhang Y, et al. (2026) Impact of COVID-19 restrictions on thyroid cancer diagnoses in a comprehensive cancer center (2017–2023) . PLoS One 21(1): e0340347 .  \n[https://doi.org/10.1371/journal.pone.0340347](https://doi.org/10.1371/journal.pone.0340347)  \nEditor: Fateen Ata, Hamad Medical Corporation, QATAR  \nReceived: August 28, 2025  \nAccepted: December 20, 2025  \nPublished: January 15, 2026  \nCopyright: © 2026 Mann et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: Data cannot be shared publicly because they contain protected health information (e.g., service dates) . Qualified researchers who meet the criteria for access to confidential data may request access through the University of Wisconsin–Madison  \nRESEARCH ARTICLE  \nImpact of COVID-19 restrictions on thyroid cancer diagnoses in a comprehensive cancer center (2017–2023)  \nHayley Mann1, Erin Dimon1, Yichi Zhang2, Natalia Arroyo3, Abdullah Adil4,  \nYanchen Zhang1, Oguzhan Alagoz2, Sara Fernandes-Taylor5, Erin J. Aiello Bowles6, Louise Davies7,8,9, David O. Francis1*  \n1 Department of Otolaryngology Head & Neck Surgery, University of Wisconsin School of Medicine and Public Health, Madison Wisconsin, United States of America, 2 Department of Industrial and Systems Engineering, College of Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America, 3 UW Carbone Cancer Center, School of Medicine and Public Health, University of WisconsinMadison, Madison, Wisconsin, United States of America, 4 Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, United States of America, 5 Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison Wisconsin, United States of America, 6 Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, United States of America, 7 The VA Outcomes Group, Department of Veterans Affairs Medical Center, White River Junction, Vermont, United States of America, 8 Section of Otolaryngology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America, 9 The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire, United States of America  \n* [dofrancis@wisc.edu](dofrancis@wisc.edu)  \nAbstract  \nIntroduction  \nThe Coronavirus 2019 (COVID-19) pandemic disrupted healthcare delivery across the United States, leading to a sharp decline in outpatient visits. Given that thyroid nodule evaluation and diagnosis typically occur in outpatient settings, we hypothesized that these disruptions would reduce thyroid cancer incidence. This study evaluates trends in thyroid cancer diagnosis, treatment, and outcomes at a U.S. comprehensive cancer center from 2017 to 2023.  \nMethods  \nWe included adults with pathologically confirmed thyroid cancer diagnosis between January 1, 2017, and December 31, 2023. Primary analyses assessed (1) annual percent change (APC) in thyroid cancer incidence from 2017–2023 and (2) incidence trends across three periods: pre-pandemic (Jan 2017–Mar 2020), pandemic (Apr 2020–Mar 2021), and COVID-years (Apr 2021–Dec 2023) . Annual incidence rates were calculated using the total number of individuals cared for within our health system each year as the denominator. Secondary outcomes included tumor size, extent and timing of surgery, and 1-year all-cause mortality across time periods.  \nPLOS One | [https://doi.org/10.1371/journal.pone.0340347](https://doi.org/10.1371/journal.pone.0340347) January 15, 2026 1 / 10  \nInstitutional Data Access/Ethics Committee by contacting [dapir@provost.wisc.edu](dapir@provost.wisc.edu).  \nFunding: This work is supported by Nat","cbCaitytv7hBQPpu","https://ap.wps.com/l/cbCaitytv7hBQPpu","pdf",416015,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What time periods were compared for thyroid cancer diagnoses?\",\"answer\":\"The analysis compared pre-pandemic (Jan 2017–Mar 2020), pandemic (Apr 2020–Mar 2021), and COVID-years (Apr 2021–Dec 2023).\"},{\"question\":\"How did thyroid cancer incidence change from 2017 to 2022?\",\"answer\":\"Age- and sex-adjusted incidence declined from 34 to 15.6 per 100,000 persons between 2017 and 2022, with an average APC of −14.4%. \"},{\"question\":\"Were tumor size and 1-year mortality different across the timeframes?\",\"answer\":\"No significant differences were observed in tumor size, surgical treatment, gender ratio, or 1-year all-cause mortality across the evaluated timeframes.\"}]","Impact of COVID-19 restrictions on thyroid cancer diagnoses in a comprehensive cancer center (2017-2023) - Research Report | PDF",1790146716,25,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8074ccc873947275179db77b2da3e84d.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4692beb96eff656275c62f17a8171ebf.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdca1da2f8f238e719fd953f2f459234.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e17796092e1a28e2932d50916dd56035.webp",980,1268]